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Enhanced Green Fluorescent Protein (EGFP) is the most commonly used live cell reporter despite a number of conflicting
reports that it can affect cell physiology. Thus far, the precise mechanism of GFP-associated defects remained unclear. Here we
demonstrate that EGFP and EGFP fusion proteins inhibit polyubiquitination, a posttranslational modification that controls
a wide variety of cellular processes, like activation of kinase signalling or protein degradation by the proteasome. As
a consequence, the NF-kB and JNK signalling pathways are less responsive to activation, and the stability of the p53 tumour
suppressor is enhanced in cell lines and in vivo. In view of the emerging role of polyubiquitination in the regulation of
numerous cellular processes, the use of EGFP as a live cell reporter should be carefully considered.
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INTRODUCTION
The extensive use of EGFP as a live cell reporter is based on the
presumption that it does not affect (important) cellular functions.
Nevertheless, a number of side effects have been reported. First
a link between expression of GFP and induction of apoptosis was
observed in number of cell lines [1]. In endothelial cells, the
introduction of GFP by various gene transfer vectors selectively
induced HSP70 resulting in the up-regulation of cyclooxygenase-2
(COX-2) expression followed by prostaglandin E2 production [2].
Recently, EGFP was shown to impair actin-myosin interactions in
heart muscle cells [3], which might be linked to the dilated
cardiomyopathy phenotype reported earlier on for GFP transgenic
mice [4]. Furthermore, co-expression of EGFP and beta-
galactosidase in neurons of transgenic mice induced neuropathol-
ogy and premature death [5]. Up till now, the mechanism by
which GFP provokes these defects remains undefined.
Ubiquitination is a posttranslational modification in which
single or multiple ubiquitin molecules are attached to a protein. To
date, two major forms of polyubiquitination have been function-
ally characterized, in which the isopeptide bond linkages involve
Lys48 or Lys63. Typically, a polyubiquitin chain linked through
Lys 48 targets a protein for degradation by the proteasome [6].
For example, the p53 tumour suppressor has to be maintained at
a low steady-state level in most physiological conditions because of
its inhibitory effect on cell growth. This duty is mainly fulfilled by
MDM2, an E3 ubiquitin ligase that triggers constant degradation
of p53 through Lys48-linked polyubiquitination [7,8]. In contrast,
Lys63-linked polyubiquitination serves a regulatory function via
a degradation-independent mechanism and has been reported to
control protein-kinase activation in NF-kB signalling [9].
In the present work we describe that EGFP blocks both Lys63-
and Lys48-linked polyubiquitination and affects in this way NF-kB
and JNK signalling and p53 homeostasis.
RESULTS AND DISCUSSION
Constitutive activation of the transcription factor NF-kBi s
considered essential for B-cell transformation by the API2-
MALT1 fusion protein of MALT lymphomas with a translocation
t(11;18) [10]. Transient overexpression of API2-MALT1 in 293T
cells results in the robust activation of an NF-kB luciferase reporter
gene [11], thereby providing a useful model system to study the
mechanisms by which API2-MALT1 signals to NF-kB. To monitor
for transfection efficiency, we co-expressed pEGFP-N2 (Clontech)
in a number of experiments. To our surprise we observed that
EGFP inhibited NF-kB activation induced by API2-MALT1 in
a dose dependent manner (Fig 1A). In contrast, EGFP did not
affect reporter activation induced by expression of the p50/p65
subunits of NF-kB (Fig 1B), suggesting an interference with the
NF-kB signalling cascade activated by API2-MALT1 upstream of
NF-kB.
MALT1 is an essential signalling component of the antigen-
receptor pathway towards NF-kB [12,13]. It is believed that
BCL10 mediates oligomerization of MALT1, which allows the
formation of a complex with TRAF6. Oligomerization of TRAF6
elicits the E3 ubiquitin ligase activity of its RING domain,
resulting in modification of IKKc (NEMO) via Lys63-linked
polyubiquitin chains. This facilitates then the interaction of IKKc
with TGFb activating kinase 1 (TAK1), which fully activates the
IkB kinase complex (IKK) via phosphorylation of IKKb [14],
thereby leading to NF-kB activation. Similarly, the API2-MALT1
fusion protein activates NF-kB via TRAF6-mediated polyubiqui-
tination of IKKc [10,15]. The interaction of TRAF6 with the
Carboxy-terminus of MALT1 occurs via two potential TRAF6
binding motifs (PxExxAr/Ac with Ar/Ac for an aromatic or acidic
residue [16]. Inspection of the EGFP sequence revealed the
presence of a TRAF6 binding consensus (PNEKRD, AA 212–
217). The crystal structure of EGFP shows that the PNEKRD
motif is exposed in a loop between two beta-sheets [17], suggesting
its accessibility and a role for EGFP as negative regulator via
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demonstrate an interaction between EGFP and TRAF6 (data
not shown) and mutants for the TRAF6 binding consensus
blocked NF-kB activation by API2-MALT1 as efficient as EGFP
(Fig 1C).
To investigate whether the effect was limited to API2-MALT1,
we analyzed TNF-a induced NF-kB activation in 293T cells
expressing EGFP. Again, EGFP reduced NF-kB signalling as
demonstrated by lower reporter activity and reduced phosphor-
ylation of the inhibitor of NF-kB, IkB-a (Fig 1D). Next we
evaluated whether EGFP fusion proteins might have the same
effect. Both N- and C-terminal EGFP fusions blocked API2-
MALT1- (data not shown) and TNFa-induced NF-kB activation
(Fig 1E). Besides activating the NF-kB pathway, TNF-a treatment
also triggers JNK signalling. Phosphorylation of JUN, indicative
for activated JNK signalling, is reduced by EGFP as well after
TNF-a treatment (Fig 1D).
It has been reported that prolonged visualization of GFP
expressing cells induces the production of reactive oxygen species,
which can result in physiological changes and eventually cell death
[18]. Interestingly, both EGFP mutants for the TRAF6 binding
consensus had lost their green fluorescence but efficiently inhibited
NF-kB signalling (Fig 1C). Furthermore, pmaxGFP (Amaxa
Biosystems), a structurally different fluorescent protein, did not
effect NF-kB and JNK activation upon TNF-a treatment (Fig 1D),
suggesting that the inhibition did not result from free-radical-
associated phototoxicity. Another study indicated that high levels
of EGFP can induce heat shock protein 70 (HSP70) [2], which is
able to inhibit NF-kB activation via its interaction with IKKc [19]
and TRAF6 [20]. However, induction of HSP70 was restricted to
endothelial cells [2] and we did not observe increased HSP70
levels or induction of HSP70B9 in EGFP expressing 293T cells
(Fig 1D–E).
NF-kB activation by API2-MALT1 expression or upon TNF-
a treatment is associated with modification of IKKc with Lys63-
linked polyubiquitin by TRAF6 or TRAF2 respectively [10,21].
Furthermore TNFa-induced JNK signalling requires TRAF2
auto-ubiquitination [22]. To assess a possible effect of EGFP on
the RING E3 ubiquitin ligase activity of TRAF6 or TRAF2, we
monitored ubiquitination via a HA-tagged ubiquitin-mutant with
only Lys63 available for polymerization (HA-Ub-K63). Expression
of API2-MALT1 or TNF-a stimulation increased the level of
polyubiquitinated proteins in 293T cells and was associated with
Figure 1. EGFP inhibits NF-kB and JNK activation in 293T cells. (A)
Activation of an NF-kB luciferase reporter by a Flag-tagged API2-MALT1
fusion protein is inhibited by EGFP in a dose dependent manner. (B)
EGFP does not block NF-kB dependent luciferase activity induced by
r
expression of the p50/p65 subunits of NF-kB( C) Activation of an NF-kB
luciferase reporter by Flag-API2-MALT1 is inhibited by EGFP mutated
for the TRAF6 binding motif (D) EGFP but not pmaxGFP prevents
TNF-a induced activation of the NF-kB luciferase reporter and
phosphorylation of IkB-a and JUN in 293T cells. EGFP does not increase
HSP70 levels or induce HSP70B9 in 293T cells. Fluorescence intensities
(Ex485/Em520nm) for EGFP and pmaxGFP were both ,100 fold above
background. (E) N- and/or C-terminal EGFP fusion proteins (for API2,
CHIC2, NXF5a, NXF1, MALT1, Actin, Rab5, Syndecan binding protein 2
(SDCBP2) or b-Tubulin) and EGFP with a nuclear localization signal (NLS)
or a farnysilation site (pEGFP-F) reduce TNF-a-induced NF-kB luciferase
reporter activity in 293T cells. Bottom: In humans, HSP70 is constitu-
tively expressed under normal conditions, but Hsp70B9 is only induced
in response to stress. There is no basal expression of Hsp70B9[28]. As
a positive controle for HSP70B9 expression, 293T cells (lane 2) were heat
shocked at 44uC for two hours (lane 3) and allowed to recover at 37uC
for 5 (lane 4) or 18 (lane 5) hours before harvest. NF-kB-dependent
luciferase activity is represented for each experiment as fold induction
of vector transfected cells and is represented graphically as the mean
and standard deviation of at least three independent experiments. All
molecular weight standards are in kDa.
doi:10.1371/journal.pone.0000054.g001
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both processes were blocked by EGFP (Fig 2A, lanes 1,2,5,6).
Moreover EGFP reduced the basal level of K63-linked poly-
ubiquitination in 293T cells (Fig 2A, lanes 3 and 4). Similarly,
expression of API2-MALT1 or TNFa treatment stimulates K48-
linked ubiquitin chain assembly, which is again blocked by EGFP
and its structural homologue dsRed (Clontech) but not by
pmaxGFP (Fig 2B).
To investigate whether EGFP exclusively affects ubiquitination
by TRAF proteins, we evaluated API2, a RING E3 ubiquitin
ligase that destabilizes itself via Lys48-linked auto-ubiquitination
[23]. Co-expression of EGFP inhibited polyubiquitination induced
by API2 in 293T cells resulting in an increase of API2 expression
levels (Fig 2C). Reduced steady-state levels of ubiquitination were
also observed in MCC14.2 cells with stable expression of EGFP.
As a consequence, basal levels of endogenous p53, which are
tightly regulated through Lys48-linked ubiquitination by MDM2,
are slightly increased in EGFP expressing cells (Fig 2D).
Next we examined whether EGFP affects ubiquitination in vivo.
The basal levels of polyubiquitination were reduced in splenic
lymphocytes from EGFP transgenic mice [24], which was
associated with reduced phosphorylation of IkB-a following
antigen stimulation compared to control mice, indicating that
EGFP reduces B-cell receptor-induced NF-kB activation (Fig 3A–
B). API2-MALT1 transgenic mice have a deficit of B220
+/CD40
+
B-cells in their bone marrow as API2-MALT1-mediated NF-kB
activation accelerates their maturation to naı ¨ve B-cells [15]. When
these API2-MALT1 transgenic mice were crossed with EGFP
mice, the deficit of B220
+/CD40
+ B-cells in the bone marrow of
EGFP/API2-MALT1 double transgenic mice (Fig 3C) was
restored, further supporting an impact on ubiquitination and
NF-kB signalling in vivo. Similarly, polyubiquitination was reduced
in liver cells of EGFP mice and was associated with p53
stabilization as shown by the increase of its expression level
(Fig 3A, D). The major target gene of p53 upon c-irradiation-
induced DNA damage in the liver is p21, which is required for cell
cycle arrest and DNA repair [25]. Accordingly, c-irradiation
induced DNA damage caused not only a higher p53 response in
EGFP mice but also the induction of p21 was slightly enhanced
(Fig 3D). Finally in vitro experiments were performed to evaluate
whether EGFP directly affects ubiquitin chain assembly; however
recombinant EGFP did not affect polyubiquitination of a control
substrate (Fig 3E), suggesting a cell context dependent effect of
EGFP on ubiquitination.
In conclusion, our data indicate that EGFP and EGFP fusion
proteins affect RING E3 ubiquitin ligase-dependent processes like
NF-kB and JNK signalling or p53 homeostasis in cell lines and in
mice. NF-kB plays a central role in the regulation of diverse
Figure 2. EGFP blocks Lys63- and Lys48-linked polyubiquitination.( A) 293T cells transfected with the indicated constructs and treated for 4 hours
with 20 ng/ml TNF-a (lane 5 and 6) were immunoblotted with anti-Flag (API2-MALT1), anti-HA (HA-Ub-K63) and anti-EGFP antibodies (left panel) or
anti-IKKc immunoprecipitates were immunoblotted with anti-Flag (IKKc) or anti-HA (ubiquitin) (right panel). (B) EGFP affects K48-linked
polyubiquitination. 293T cells were transfected with a Ubiquitin construct with only Lys48 available for polymerization (HA-Ub-K48), treated for
4 hours with 20 ng/ml TNF-a or left untreated and cell lysates were immunoblotted with anti-HA (Ub-K48) and anti-EGFP antibodies. Fluorescence
intensities (Excitation 485/Emission 520 nm) for EGFP and pmaxGFP were comparable (,100 fold higher then background values), expression of pDs-
Red was confirmed by Fluorescence microscopy. (C) EGFP stabilizes exogenous API2-Myc in 293T cells via reduction of its Lys48-linked auto-
ubiquitination and proteasomal degradation. (D) Stable expression of EGFP in the merkel cell carcinoma cell line MCC14.2 reduces polyubiquitination
and enhances endogenous p53 expression levels. The average ratio and standard deviation of p53 to actin signals are given (three independent
experiments), (Ub)
n : polyubiquitinated proteins.
doi:10.1371/journal.pone.0000054.g002
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development, cell growth and survival [26]. The pro-survival
signals result from the elevated expression of inhibitors of
apoptosis, such as B-cell leukaemia/lymphoma-XL. Therefore,
the increase in apoptosis induced by EGFP in cells [1] or in the
motor cortex and striatum of the brain of mice [5] might be
related to reduced NF-kB activity due to defective polyubiquitina-
tion and activation/degradation of its upstream regulators.
Defective ubiquitination is also postulated to cause limb girdle
muscular dystrophy, which is associated with mutations in
Trim32, a ubiquitin ligase for actin [27]. Because EGFP was
shown to impair actin-myosin interactions in muscle cells [3] and
to induce dilated cardiomyopathy in EGFP mice [4], it is tempting
to speculate that actin ubiquitination might play an essential role
in normal muscle functioning and that its deregulation by
EGFP causes the above mentioned phenotypes. Therefore, in
view of the emerging role of ubiquitination in numerous cellular
processes, the use of EGFP as a live cell reporter should be
carefully considered.
MATERIALS AND METHODS
Plasmids and reagents
The open reading frames of API2-MALT1, p50, p65 and IKKc
were amplified by RT-PCR using Long Distance PCR (Roche
Applied Science) and cloned in pcDNA3.1 with an N-terminal
Flag-tag. Ubiquitin and ubiquitin-mutants with only Lys48 or
Lys63 available for polymerization were generated via PCR and
cloned in pcDNA3.1 with an N-terminal HA-tag. pEGFP-N1 and
pDsRed were from Clontech, pmaxGFP that encodes the green
fluorescent protein (GFP) from Copepod Pontellina plumata from
Amaxa Biosystems.
Antibodies specific for Ubiquitin (sc-8017), Actin (sc-8432),
IKKc (FL-419), p53 (DO-1) and HSP70 (K-20) were from Santa
Cruz Biotechnology; anti-HSP70B9 from Stressgen, anti-EGFP
and anti-Flag from Sigma-Aldrich, anti-HA (12CA5) from Roche
Applied Science,andanti-p21 (DCS60),anti-Phospho-IkB-a(5A5),
anti-Phospho-c-Jun (Ser63) (#9261) and anti-c-Jun (#9162) were
from Cell Signaling.
Figure 3. EGFP affects polyubiquitination-dependent processes in vivo.( A) Western blots of spleen and liver extracts from FVB wild-type (wt) and
EGFP transgenic mice detected with antibodies against Ubiquitin, EGFP and actin (loading control). (B) EGFP reduces phosphorylation of IkB-a in anti-
IgM/anti-CD40 stimulated B-lymphocytes purified from EGFP mice. Experiments performed in triplicate, a representative image of one experiment is
shown. The average and standard deviations of ratios of IkB-a-P to actin relative to un-stimulated cells are given. (C) The deficit of B220
+/CD40
+ B-
cells in the bone marrow of API2-MALT1 mice is restored in EGFP/API2-MALT1 double transgenic mice. Experiments performed in triplicate, the
average and standard deviations are depicted. eMalt1: endogenous Malt1, *a-specific band (D) EGFP mice show increased p53 levels in the liver and
have enhanced p53/p21 responses upon c-irradiation induced DNA damage. The average and standard deviations of the ratios of p53/p21 to actin
signals relative to that of sample 1 are given. (E) Recombinant EGFP (rEGFP) does not prevent polyubiquitination of a Biotin-Lysozyme substrate in
vitro. (Ub)
n: polyubiquitinated proteins.
doi:10.1371/journal.pone.0000054.g003
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polyubiquitination
HEK293T were cultured in DMEM-F12 medium (Invitrogen)
supplemented with 10% fetal calf serum at 37uC in 5% CO2.
5610
5 HEK293T-cells were transfected with 1 mg of DNA
containing 20 ng of a NF-kB luciferase reporter (pIgk3ConALuc),
20 ng of a b-galactosidase expression vector (pEL1-b-gal), a
mixture of the expression constructs to test (2–200 ng) and the
appropriate empty parental expression vector to keep the total
amount of DNA at 1 mg per well of a six-well plate using Gene
Juice transfection reagent (Novagen). 24 hours post-transfection,
cells were harvested in 16 PBS, lysed in Passive lysis buffer
(Promega) and assayed for luciferase and b-galactosidase activities
using a Fluostar galaxy plate reader (BMG Labtechnologies). Fold
NF-kB induction was calculated by dividing the luciferase activity,
normalized to b-galactosidase activity for each sample, by that
observed in the control containing only empty vector.
For the detection of IKKc polyubiquitination, lysates from
HEK293T-cells transfected with pcD-F-IKKc/pcD-HA-Ub-K63
together with pcD-F-API2-MALT1 or empty vector or transfected
with pcD-F-IKKc/pcD-HA-Ub-K63 and treated for 4 hrs with
20 ng/ml TNFa (hBA-158, Santa Cruz) respectively were pre-
cleared with protein G-sepharose (Amersham Biosciences) for
2 hours prior to immunoprecipitation overnight with an antibody
against IKKc. Immunoprecipitates were washed four times in
lysis buffer, resolved by SDS-PAGE and detected with anti-HA or
anti-Flag.
Transgenic GFP mice [24] had been backcrossed for at least
20 generations in strain FVB (Charles River laboratories) and bred
as EGFP homozygotes. API2-MALT1 heterozygous transgenic
mice generated in strain FVB [15] were crossed with EGFP
transgenic mice to obtain EGFP/API2-MALT1 double transgenic
and EGFP heterozygotes. All animal experiments were performed
in accordance with institutional guidelines.
IgM/CD40 stimulation of purified splenic
B-lymphocytes
Single cell suspensions were prepared from spleens of healthy FVB
and FVB-EGFP mice (12 weeks) and B-cells were isolated by
negative selection (murine B-cell selection kit, Miltenyibiotech)
according to the manufacturer’s instructions. 15610
6 cells were
stimulated with anti-IgM (10 mg/ml, Sigma-Aldrich) and anti-
CD40 (2 mg/ml, BD Biosciences) for the indicated times.
In vitro ubiquitination assay
The ubiquitination reactions were performed with the Ubiquitin-
Protein Conjugation kit (K-960, Boston Biochemicals) with Biotin-
Lysozyme as conjugation substrate (SP-100, Boston Biochemicals)
in the presence of Ubiquitin aldehyde. Reactions were stopped by
addition of reducing sample buffer and boiling for 1 min.
Recombinant EGFP was purchased from Biovision.
Flow cytometric analyses
Single-cell suspensions of bone marrow were labeled with PerCP-
B220 and phycoerythrin-CD40 antibodies (BD Biosciences) and
stained cells were analyzed with a FACSort (BD Biosciences) using
the CELLQUEST software.
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